Form 4: ARTIVION Director Jeffrey Burbank Receives Equity Grant, Boosting Holdings to Over 53,000 Shares

ARTIVION, INC. Director Jeffrey H. Burbank was granted 6,325 shares of common stock as part of an equity incentive plan, increasing his total beneficial ownership to 53,796 shares.

Summary

• Jeffrey H. Burbank, a Director of ARTIVION, INC. (AORT), acquired 6,325 shares of common stock on May 22, 2025.
• The acquisition was an equity grant with a reported price of $0 per share, indicating a Restricted Stock Award (RSA).
• These granted shares are scheduled to vest on May 22, 2026, in accordance with the company's Equity and Cash Incentive Plan.
• Following this transaction, Mr. Burbank's total beneficial ownership in ARTIVION, INC. stands at 53,796 shares of common stock.

Sentiment

Score: 6

Explanation: Slightly positive. While a routine compensation grant, it increases insider ownership, which generally aligns management's interests with shareholders. It does not indicate any negative operational or financial news.

Positives

• The grant of additional shares to a director aligns management's interests with those of shareholders, as their compensation becomes more tied to the company's stock performance.
• An increase in insider holdings, even through grants, can signal confidence in the company's future prospects by its leadership.

Future Outlook

The acquired shares are part of a Restricted Stock Award (RSA) that will vest on May 22, 2026, indicating a future milestone for the director's equity compensation.

Management Comments

• The transaction reflects the company's ongoing use of its Equity and Cash Incentive Plan to compensate and align its directors with shareholder interests.

Industry Context

This Form 4 filing is a routine disclosure of an insider equity transaction, common across publicly traded companies as part of their executive and director compensation programs. Such grants are standard practice to incentivize long-term performance and retention within the medical device or healthcare industry, where ARTIVION operates.

Stakeholder Impact

• Shareholders: The grant of shares to a director can be viewed positively as it further aligns the director's financial interests with the long-term performance of the company, potentially leading to more shareholder-friendly decisions.

Next Steps

• The 6,325 Restricted Stock Award shares granted to Jeffrey H. Burbank are expected to vest on May 22, 2026.

Key Dates

Keywords

ARTIVION, AORT, Jeffrey H. Burbank, Form 4, Insider Transaction, Equity Grant, Restricted Stock Award, Director Compensation, Beneficial Ownership